Search - tctmd.com

Displaying 141 - 160 of 238

Sort: Relevancy | Date

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

Presentation TCT 2013

TCT-62. Preliminary Result of the Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the Maya Medical OneShot™ Ablation System (RAPID) Study.

Presenter: Stefan Verheye

October 29, 2013

News Industry News

New Data from St. Jude Medical Study of EnligHTN Renal Denervation System Presented Today at Scientific Symposium

October 29, 2013

News Industry News

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

October 29, 2013

Presentation TCT 2013

EnligHTN 1: 18-Month Results from a Prospective Registry Study of Renal Denervation in Patients with Resistant Hypertension

Presenter: Stephen Worthley

October 28, 2013

News Conference News TCT 2013

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

October 28, 2013

News Conference News TCT 2013

Preliminary Data Show Potential of Renal Denervation in Several Settings

October 28, 2013

News Industry News

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

October 28, 2013

News Conference News TCT 2013

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

October 28, 2013

News Industry News

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

October 28, 2013

Presentation TCT 2013

Moderate Treatment Resistant Hypertension: A New Indication for RDN?

Presenter: David Kandzari

October 27, 2013

Presentation TCT 2013

Is the Noncompliant Patient with Severe Treatment Resistant Hypertension an Appropriate Candidate for this Technology?

Presenter: Robert Whitbourn

October 27, 2013

Presentation TCT 2013

Cost-Effectiveness of Catheter-Based Renal Denervation in Severe Treatment Resistant Hypertension

Presenter: Jan Pietzsch

October 27, 2013

News Daily News

La Sensibilidad Baro-refleja podría ayuda a Localizar a Probables Respondedores a la Denervación Renal

September 13, 2013

News Daily News

Baroreflex Sensitivity May Help Target Likely Responders to Renal Denervation

September 13, 2013

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

Caitlin E. Cox

September 04, 2013

News Industry News

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

September 03, 2013

News Industry News

Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity(TM) Renal Denervation System from the Global SYMPLICITY Registry

September 02, 2013

Presentation

Impaired Cardiac Baroreflex Sensitivity (BRS) Predicts Response to Renal Denervation in Patients with Resistant Hypertension

Presenter: C. S. Zuern

August 22, 2013

Advertisement

Innovation in Intervention: Perspectives from Industry

TCT-62. Preliminary Result of the Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the Maya Medical OneShot™ Ablation System (RAPID) Study.

New Data from St. Jude Medical Study of EnligHTN Renal Denervation System Presented Today at Scientific Symposium

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

EnligHTN 1: 18-Month Results from a Prospective Registry Study of Renal Denervation in Patients with Resistant Hypertension

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

Preliminary Data Show Potential of Renal Denervation in Several Settings

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

Moderate Treatment Resistant Hypertension: A New Indication for RDN?

Is the Noncompliant Patient with Severe Treatment Resistant Hypertension an Appropriate Candidate for this Technology?

Cost-Effectiveness of Catheter-Based Renal Denervation in Severe Treatment Resistant Hypertension

La Sensibilidad Baro-refleja podría ayuda a Localizar a Probables Respondedores a la Denervación Renal

Baroreflex Sensitivity May Help Target Likely Responders to Renal Denervation

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity(TM) Renal Denervation System from the Global SYMPLICITY Registry

Impaired Cardiac Baroreflex Sensitivity (BRS) Predicts Response to Renal Denervation in Patients with Resistant Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content